Weekly Charts with Rhum (XLY, SCOT, LHS, BU)

Here’s another edition of our chart-based weekly with our FinTwit friend Rhum.

Every week he breaks down the weekly charts from some of the hottest tickers out there. These charts will show you some of the most hyped-up names of the week, and maybe even a few that might be good buying opportunities.

If you like the charts, don’t forget to support Rhum and his blog for his hard work and don’t hesitate to send in any chart requests either.

XLY – 2.0 May Not Offer Reprieve

Like much of the industry, Auxley Cannabis [stock_market_widget type="inline" template="generic" color="default" assets="XLY.V" markup="(TSXV: {symbol} {currency_symbol}{price} ({change_pct}))" api="yf"] has seen trading volumes fall along with its stock price. While many are hoping 2.0 product offerings could save the day, according to Rhum, their CBD gummies don’t perform any better than their share price.

Trade this one at your own risk.

SCOT – Golden Cross for Gold Explorer

Scottie Resources [stock_market_widget type="inline" template="generic" color="default" assets="SCOT.V" markup="(TSXV: {symbol} {currency_symbol}{price} ({change_pct}))" api="yf"] is an exploration company focused on gold and silver assets in BC’s golden triangle. Luckily for investors, they broke the downtrend with a golden cross.

With precious metals pricing outlook strong, this explorer may see some positive upward pressure over 2020.

LHS – Solid Earnings But No Pop

Liberty Health Sciences [stock_market_widget type="inline" template="generic" color="default" assets="LHS.CN" markup="(CSE: {symbol} {currency_symbol}{price} ({change_pct}))" api="yf"] released Q3 earnings last week and showed impressive growth and improving margins. Unfortunately, there was little movement in the stock price.

Overall, a slow and steady growth is likely healthier for the stock and the chart is suggesting investors may start to see the growth they are looking for.

BU – Buy on the Sell?

Burcon Nutrascience [stock_market_widget type="inline" template="generic" color="default" assets="BU.TO" markup="(TSX: {symbol} {currency_symbol}{price} ({change_pct}))" api="yf"] is a plant-based protein manufacturer with a partnership with food and beverage conglomerate Nestle. They recently announced a $10 million private placement, leading to a massive gap up.

Clearly many investors have been selling the news, however, the uptrend has held. Watch closely to see whether the bears win out or get brushed off.

If you appreciated the chart commentary by Rhum, keep in mind this isn’t his day job and he’s doing this to help investors. If you’ve made money based on his charting, don’t be afraid to give a little back.

0 0 votes
Article Rating

The opinions provided in this article are those of the author and do not constitute investment advice. Readers should assume that the author and/or employees of Capital 10X hold positions in the company or companies mentioned in the article. For more information, please see our Content Disclaimer.

Evan Veryard
Evan Veryard has a Bachelor's of Chemical Engineering from McGill University and a MaSc. of Chemical Engineering from RMC. He has over 6 years of research experience focusing on industrial materials. Address: 682 Indian Road, Toronto, Ontario, M6P 2C9. Phone: 416-721-8257.
Notify of
Inline Feedbacks
View all comments